Nagpur: Ahead of World Blood Donor Day on June 14, the Thalassemia and Sickle Cell Society of India (TSCSI) has launched Raktamitra Abhiyaan, a unique initiative aimed at improving transfusion safety and ensuring a reliable blood supply for transfusion-dependent patients.
How the Initiative Works
The programme introduces the concept of creating dedicated donor groups to "adopt" individual thalassemia patients, linking a fixed pool of voluntary blood donors to a specific child requiring regular transfusions. Doctors associated with the initiative said thalassemia patients require lifelong blood transfusions every two to three weeks.
Frequent transfusions from multiple and changing donors can increase the risk of complications, including development of antibodies that can make future transfusions more challenging. By ensuring that a patient receives blood from a known and committed donor group, the initiative seeks to improve transfusion compatibility, enhance safety and provide long-term support to families managing chronic blood disorders.
Announcement and Plans
Announcing the initiative, TSCSI President and pediatrician Dr Vinky Rughwani said voluntary blood donation remains the safest and most sustainable way to maintain an adequate supply of blood. The society plans to create a pool of at least 1,000 voluntary donors and match them according to blood groups with children enrolled at its thalassemia and sickle cell daycare centre.
Under the programme, each child will be assigned 10 to 15 dedicated donors who can donate blood regularly whenever required. The initiative is expected to strengthen the existing blood donation ecosystem while ensuring a more dependable supply of blood for transfusion-dependent patients.
Addressing Blood Shortages
Dr Rughwani said India continues to face periodic blood shortages despite significant progress in blood collection. "During the recent summer months, the number of voluntary donors declined, resulting in shortages at blood banks. Such situations are extremely difficult for thalassemia patients and their families, who depend on timely transfusions for survival," he said.
